Dementia poses a major health challenge with no safe, affordable treatments to slow its progression. Researchers at Lawson ...

A 12-month clinical trial investigated whether a cough medicine used in Europe called Ambroxol can slow dementia in people with Parkinson’s.

Every year, tens of thousands of people with signs of Parkinson's disease go unnoticed until the incurable neurodegenerative condition has already ...

A drug used for Parkinson's disease has been shown to be effective in reducing the symptoms of difficult to treat depression, ...

About half of those diagnosed with Parkinson's develop dementia within 10 years, profoundly affecting patients, families and the health care system ...

Understand Parkinson's disease, its symptoms, and the crucial role of clinical trials in treatment and research, especially for Black Americans.

Despite a significant improvement in symptoms, around 20% of patients discontinued treatment due to adverse events.

As Congress works to set funding levels for the National Institutes of Health, several advocacy groups for Parkinson’s disease research and initiatives are calling on lawmakers to ensure robust ...

Researchers at Simon Fraser University reveal how brain imaging techniques can explain the inconsistent effects of levodopa ...

Simon Fraser University researchers are pioneering personalized Parkinson's treatment using MEG imaging. They discovered that ...

Drastic cuts to NIH will halt brain research on the cusp of transformational treatments. These setbacks could derail future ...